title: Structural basis of agonist-induced desensitization and sequestration of the P2Y2 nucleotide receptor. Consequences of truncation of the C terminus.
abstract: Molecular determinants of P2Y2 receptor desensitization and sequestration have been investigated. Wild-type P2Y2 receptors and a series of five C-terminal truncation mutants of the receptor were epitope-tagged and stably expressed in 1321N1 cells. These constructs were used to assess the importance of the intracellular C terminus on 1) UTP-stimulated increases in intracellular calcium concentration, 2) homologous desensitization of the receptor, and 3) agonist-induced decreases in cell-surface density (receptor sequestration) of epitope-tagged receptors using fluorescence-activated cell sorting. The potency and efficacy of UTP were similar for the wild-type and all mutant P2Y2 receptors. Truncation of 18 or more amino acids from the C terminus increased by approximately 30-fold the concentration of UTP necessary to desensitize the receptor. Both the rate and magnitude of UTP-induced receptor sequestration were decreased with progressively larger truncations of the C terminus. Furthermore, the recovery from sequestration was slower for the most extensively truncated receptor. Complete desensitization was obtained with >50% of the original receptor complement remaining on the cell surface. Protein kinase C activation, which desensitizes the P2Y2 receptor, had no effect on sequestration, consistent with the ideas that desensitization and sequestration are discrete events and that agonist occupancy is required for receptor sequestration.
authors.affiliation: Department of Biochemistry, University of Missouri, Columbia, Missouri 65212, USA.
authors.forename: R C
authors.initials: RC
authors.lastname: Garrad
authors.forename: M A
authors.initials: MA
authors.lastname: Otero
authors.forename: L
authors.initials: L
authors.lastname: Erb
authors.forename: P M
authors.initials: PM
authors.lastname: Theiss
authors.forename: L L
authors.initials: LL
authors.lastname: Clarke
authors.forename: F A
authors.initials: FA
authors.lastname: Gonzalez
authors.forename: J T
authors.initials: JT
authors.lastname: Turner
authors.forename: G A
authors.initials: GA
authors.lastname: Weisman
mesh_terms: D000595:Amino Acid Sequence; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation; D006801:Humans; D008969:Molecular Sequence Data; D011487:Protein Conformation; D011493:Protein Kinase C / Q000378:metabolism; D017433:Protein Structure, Secondary; D058910:Purinergic P2 Receptor Agonists; D018048:Receptors, Purinergic P2 / Q000737:chemistry; D058473:Receptors, Purinergic P2Y2; D011994:Recombinant Proteins / Q000819:agonists / Q000737:chemistry; D014544:Uridine Triphosphate / Q000494:pharmacology*
chemical_list: C546385:P2RY2 protein, human; D058910:Purinergic P2 Receptor Agonists; D018048:Receptors, Purinergic P2; D058473:Receptors, Purinergic P2Y2; D011994:Recombinant Proteins; D011493:Protein Kinase C; D014544:Uridine Triphosphate